These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9560133)

  • 1. Ex-UN AIDS chief is blasted for remarks on vaccine strategy.
    Wadman M
    Nature; 1998 Apr; 392(6676):527-8. PubMed ID: 9560133
    [No Abstract]   [Full Text] [Related]  

  • 2. NIH institute to work with trial of AIDS vaccine, despite concerns.
    Wadman M
    Nature; 1998 Aug; 394(6696):818. PubMed ID: 9732856
    [No Abstract]   [Full Text] [Related]  

  • 3. Army HIV vaccine to undergo clinical trial as rival is halted.
    Check E
    Nature; 2002 Mar; 416(6876):6. PubMed ID: 11882860
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines.
    Robinson HL; Weinhold KJ
    J Infect Dis; 2006 Dec; 194(12):1625-7. PubMed ID: 17109331
    [No Abstract]   [Full Text] [Related]  

  • 5. AIDS research. Debate begins over new vaccine trials.
    Cohen J
    Science; 2001 Sep; 293(5537):1973. PubMed ID: 11557856
    [No Abstract]   [Full Text] [Related]  

  • 6. Laying out the rules for AIDS vaccine trials.
    Science; 1995 Aug; 269(5227):1037. PubMed ID: 7652548
    [No Abstract]   [Full Text] [Related]  

  • 7. Global HIV vaccine enterprise appoints new director.
    McEnery R
    IAVI Rep; 2012; 16(2):20-1. PubMed ID: 22650057
    [No Abstract]   [Full Text] [Related]  

  • 8. NIAID collaborates with VaxGen on vaccine studies.
    AIDS Patient Care STDS; 1998 Nov; 12(11):874. PubMed ID: 11362049
    [No Abstract]   [Full Text] [Related]  

  • 9. NIH appoints a director for its AIDS vaccine center.
    Birmingham K
    Nat Med; 1999 Apr; 5(4):362. PubMed ID: 10202909
    [No Abstract]   [Full Text] [Related]  

  • 10. Preparations for AIDS vaccine trials. Intellectual property issues related to AIDS vaccine development from a federal laboratory perspective.
    Mays TD; Maurey K
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S301. PubMed ID: 7865325
    [No Abstract]   [Full Text] [Related]  

  • 11. An AIDS vaccine: a flickering light at the end of the tunnel.
    Kent C
    J Am Health Policy; 1994; 4(4):33-7. PubMed ID: 10136680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Support for the RV144 HIV vaccine trial.
    AIDS Vaccine Advocacy Coalition
    Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15250069
    [No Abstract]   [Full Text] [Related]  

  • 13. Weighing HIV vaccine trials.
    Science; 1994 Aug; 265(5173):735. PubMed ID: 8047878
    [No Abstract]   [Full Text] [Related]  

  • 14. NIH revamps HIV vaccine trials unit.
    Wickware P
    Nat Med; 2000 May; 6(5):488. PubMed ID: 10802685
    [No Abstract]   [Full Text] [Related]  

  • 15. Policy rebuttal. HIV vaccine trial justified.
    McNeil JG; Johnston MI; Birx DL; Tramont EC
    Science; 2004 Feb; 303(5660):961. PubMed ID: 14963313
    [No Abstract]   [Full Text] [Related]  

  • 16. The AIDS vaccine: back to the basics?
    Naper J
    Hosp Technol Ser; 1994 Nov; 13(14):11-2. PubMed ID: 10139025
    [No Abstract]   [Full Text] [Related]  

  • 17. NIAID will fund HIV vaccine trials network.
    Sweeney R; Lapp T
    Am Fam Physician; 2000 Aug; 62(4):717. PubMed ID: 10969851
    [No Abstract]   [Full Text] [Related]  

  • 18. Volunteers sought for NIH AIDS vaccine study.
    AIDS Read; 2005 Nov; 15(11):574. PubMed ID: 16329177
    [No Abstract]   [Full Text] [Related]  

  • 19. Uganda may host AIDS vaccine trial.
    Holden C
    Science; 1996 May; 272(5262):657. PubMed ID: 8614821
    [No Abstract]   [Full Text] [Related]  

  • 20. Massachusetts university to begin human HIV vaccine trials.
    AIDS Policy Law; 2004 Apr; 19(7):9. PubMed ID: 15124606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.